Related Experiment Videos
Bleomycin-induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2
Bethany B Moore1, Megan N Ballinger, Eric S White
1Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI 48109, USA. BMoore@umich.edu
Journal of Immunology (Baltimore, Md. : 1950)
|April 22, 2005
Summary
Prostaglandin E2 (PGE2) normally inhibits fibroblast activity, but its EP2 receptor is lost during lung fibrosis. This loss prevents PGE2 from suppressing fibroblast proliferation and collagen production, driving fibrotic responses.
Area of Science:
- Pulmonary Medicine
- Immunology
- Cell Biology
Background:
- Prostaglandin E2 (PGE2) is a known inhibitor of fibroblast function.
- Paradoxically, PGE2 levels increase during lung fibrotic responses in mice.
- Fibroblast function is critical in the development of pulmonary fibrosis.
Purpose of the Study:
- To investigate the role of E prostanoid (EP) receptors, specifically EP2, in the context of pulmonary fibrosis.
- To determine if altered EP receptor expression contributes to the fibrotic response despite elevated PGE2 levels.
Main Methods:
- Assessing EP receptor expression on pulmonary fibroblasts from mice before and after bleomycin-induced fibrosis.
- Evaluating fibroblast proliferation and collagen synthesis in response to PGE2.
- Measuring intracellular cAMP levels in fibroblasts stimulated with PGE2.
- Analyzing fibrotic responses in EP2 knockout mice following bleomycin challenge.
- Validating findings in a second pulmonary fibrosis model using FITC.
Main Results:
- Pulmonary fibroblasts normally express all four PGE2 EP receptors.
- Bleomycin challenge led to a loss of EP2 receptor expression on fibroblasts.
- Fibroblasts lacking EP2 expression were unresponsive to PGE2's inhibitory effects on proliferation and collagen synthesis.
- EP2 knockout mice exhibited exacerbated fibrotic lung responses compared to wild-type mice.
- Loss of EP2 on fibroblasts was confirmed in a FITC-induced fibrosis model.
Conclusions:
- Loss of the EP2 receptor on pulmonary fibroblasts is a key mechanism contributing to heightened fibrotic responses.
- This EP2 receptor downregulation impairs PGE2's ability to suppress fibroblast activity during lung injury.
- Targeting the EP2 receptor pathway may offer a novel therapeutic strategy for pulmonary fibrosis.